Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

MLA

Josef S. Smolen, et al. “Radiographic Progression Based on Baseline Characteristics from TNF Inhibitor Biosimilar Studies in Patients with Rheumatoid Arthritis.” Arthritis Research & Therapy, vol. 22, no. 1, Aug. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13075-020-02267-z.

APA

Josef S. Smolen, Young Mo Kang, Wan-Hee Yoo, Paul Emery, Michael E. Weinblatt, Edward C. Keystone, Mark C. Genovese, Gihyun Myung, Inyoung Baek, & Jeehoon Ghil. (2020). Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22(1), 1–9. https://doi.org/10.1186/s13075-020-02267-z

Chicago

Josef S. Smolen, Young Mo Kang, Wan-Hee Yoo, Paul Emery, Michael E. Weinblatt, Edward C. Keystone, Mark C. Genovese, Gihyun Myung, Inyoung Baek, and Jeehoon Ghil. 2020. “Radiographic Progression Based on Baseline Characteristics from TNF Inhibitor Biosimilar Studies in Patients with Rheumatoid Arthritis.” Arthritis Research & Therapy 22 (1): 1–9. doi:10.1186/s13075-020-02267-z.